<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have reported that facilitation of central histaminergic activity prevents the development of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>Since <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> is a major cause of brain damage, we studied effects on <z:hpo ids='HP_0002181'>brain edema</z:hpo> of postischemic administration of <z:chebi fb="0" ids="15971,29979">L-histidine</z:chebi>, a precursor of <z:chebi fb="11" ids="18295">histamine</z:chebi>, and thioperamide, a <z:chebi fb="11" ids="18295">histamine</z:chebi> H(3)-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, both of which enhance central histaminergic activity </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> for 2 h was provoked by transient occlusion of the right middle cerebral artery in rats, and the water content and <z:mpath ids='MPATH_124'>infarct</z:mpath> size were determined 24 h after reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Changes in the extracellular concentration of <z:chebi fb="11" ids="18295">histamine</z:chebi> were examined in the striatum by a microdialysis procedure, and effects of these compounds were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>Repeated administration of <z:chebi fb="0" ids="15971,29979">L-histidine</z:chebi> (1000 mg/kg x 2, i.p.), immediately and 6 h after reperfusion, reduced the increase in the water contents in ischemic regions </plain></SENT>
<SENT sid="5" pm="."><plain>Simultaneous administration of thioperamide (5 mg/kg, s.c.) with <z:chebi fb="0" ids="15971,29979">L-histidine</z:chebi> (1000 mg/kg, i.p.) completely prevented <z:hpo ids='HP_0000969'>edema</z:hpo> formation and alleviated <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, although a single dose of <z:chebi fb="0" ids="15971,29979">L-histidine</z:chebi>, immediately after reperfusion, showed no benefits </plain></SENT>
<SENT sid="6" pm="."><plain>The striatal <z:chebi fb="11" ids="18295">histamine</z:chebi> level was gradually increased after reperfusion as well as during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Simultaneous administration of thioperamide with <z:chebi fb="0" ids="15971,29979">L-histidine</z:chebi> markedly increased the brain <z:chebi fb="11" ids="18295">histamine</z:chebi> concentration, and the value increased up to 230% of that in the saline group 5 - 6 h after reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="15971,29979">L-Histidine</z:chebi> alone did not affect the increase in the <z:chebi fb="11" ids="18295">histamine</z:chebi> output after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that further activation of the central histaminergic system after initiation of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> prevents development of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
</text></document>